cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Baxter International Inc
14 own
22 watching
Current Price
$47.01
$0.73
(1.58%)
logo-bax
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
23,695.09M
52-Week High
52-Week High
89.7
52-Week Low
52-Week Low
43.25
Average Volume
Average Volume
8.99M
Dividend Yield
Dividend Yield
0.013455
P/E Ratio
P/E Ratio
32.5274
iconMarket Capitalization23,695.09M
icon52-Week High89.7
icon52-Week Low43.25
iconAverage Volume8.99M
iconDividend Yield0.013455
iconP/E Ratio32.5274
What does the Baxter International Inc do?
Baxter International Inc. provides a portfolio of renal and hospital products. The company operates through two segments, Hospital Products and Renal. The Hospital Products segment manufactures intravenous (IV) solutions and administration sets, premixed drugs and drug-reconstitution systems, pre-filled vials and syringes for injectable drugs, IV nutrition products, parenteral nutrition therapies, infusion pumps, inhalation anesthetics, and biosurgery products. This segment also provides products and services related to pharmacy compounding, drug formulation, and packaging technologies. The Renal segment provides products to treat end-stage renal disease, irreversible kidney failure, and acute kidney therapies. This segment offers products for various treatment continuums, such as technologies and therapies for peritoneal dialysis, hemodialysis, continuous renal replacement therapy, and additional dialysis services. The company sells its products for use in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and by patients at home under physician supervision. It offers its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. The company has a collaboration agreement with JW Holdings Corporation to co-develop and distribute parenteral nutritional products containing a novel formulation of omega 3 lipids; and agreement with Celerity Pharmaceutical, LLC to develop certain acute care generic injectable premix and oncolytic molecules. It also has a strategic partnership with ScinoPharm Taiwan, Ltd. to develop, manufacture, and commercialize five injectable drugs for cancer treatments, such as lung cancer, multiple myeloma, and breast cancer, as well as medication to treat nausea and vomiting, and side effects of chemotherapy. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois.
Read More
How much money does Baxter International Inc make?
News & Events about Baxter International Inc.
Globe Newswire
2days ago
Combines Miromatrixs expertise in bioengineered organs with Baxters leadership in critical care delivery and organ support therapiesIncludes intended Phase I clinical trial designed to generate key evidence to support additional therapeutic options for patients suffering from acute liver failure ...
Zolmax
26days ago
Baxter International (NYSE:BAX Get Rating) was downgraded by investment analysts at Morgan Stanley from an overweight rating to an equal weight rating in a research note issued to investors on Friday, The Fly reports. They presently have a $55.00 price target on ...
Business Wire
28days ago
Baxter International Inc. (NYSE:BAX), a leading global medtech company, today announced a comprehensive strategic roadmap to meaningfully enhance its operational effectiveness, drive toward improved long-term performance, accelerate innovation and create additional value for all stakeholders. These...
Business Wire
1month ago
Baxter International Inc. (NYSE: BAX), a global medtech leader, today announced it was again named to the Dow Jones Sustainability Indices (DJSI), including both DJSI World and DJSI North America. Baxter has proudly been included in the DJSI World and DJSI North America each year since they...
Ticker Report
2 months ago
Shares of Baxter International Inc. (NYSE:BAX Get Rating) have been assigned an average rating of Hold from the seventeen analysts that are currently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, four have given a...
Frequently Asked Questions
Frequently Asked Questions
What is Baxter International Inc share price today?
plus_minus_icon
Can Indians buy Baxter International Inc shares?
plus_minus_icon
How can I buy Baxter International Inc shares from India?
plus_minus_icon
Can Fractional shares of Baxter International Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Baxter International Inc stocks?
plus_minus_icon
What is today’s traded volume of Baxter International Inc?
plus_minus_icon
What is today’s market capitalisation of Baxter International Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Baxter International Inc?
plus_minus_icon
What percentage is Baxter International Inc down from its 52-Week High?
plus_minus_icon
What percentage is Baxter International Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$47.01
$0.73
(1.58%)
logo-bax
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Waters Corporation
Waters Corporation
$344.24
$6.21 (1.84 %)
Stryker Corporation
Stryker Corporation
$282.48
$3.53 (1.27 %)
Laboratory Corp. of America Holdings
Laboratory Corp. of America Holdings
$254.99
$4.85 (1.94 %)
Becton, Dickinson and Company
Becton, Dickinson and Company
$248.47
$-5.70 (-2.24 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.
Related Stocks
Waters Corporation
Waters Corporation
$344.24
$6.21 (1.84 %)
Stryker Corporation
Stryker Corporation
$282.48
$3.53 (1.27 %)
Laboratory Corp. of America Holdings
Laboratory Corp. of America Holdings
$254.99
$4.85 (1.94 %)
Becton, Dickinson and Company
Becton, Dickinson and Company
$248.47
$-5.70 (-2.24 %)
Sign up and dive into a whole new world of investing.
Join over 280,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00